clinical trial semaglutide New Science Suggests Improves CV Outcomes Beyond Weight Loss The SELECT Trial - A
Description
Titrate Up to 1 mg or 2.4 mg Weekly Based on Individual Response After patients stabilize on 0.5 mg, the next stage involves titration to higher doses such as 1 mg or, in some cases, up to 2.4 mg weekly

Semaglutide is a highly sought-after product, with a very large pent-up demand

JAMA 282 , 15681575 (1999)
30066-X/asset/97fa9476-8bfa-4401-a0e6-bb6e0c8b8e77/main.assets/gr3_lrg.jpg)
While semaglutide has shown great success in helping people lose weight and manage diabetes, some individuals have reported new or worsening symptoms of acid reflux or gastroesophageal reflux disease (GERD) after starting the medication

The average patient will notice results in 12 weeks
